stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. TNDM
    stockgist
    HomeTop MoversCompaniesConcepts
    TNDM logo

    Tandem Diabetes Care, Inc.

    TNDM
    NASDAQ
    Healthcare
    Medical - Devices
    San Diego, CA, US2,650 employeestandemdiabetes.com
    $18.57
    -0.24(-1.30%)

    Mkt Cap $1.3B

    $10.12
    $28.26

    52-Week Range

    At a Glance

    AI-generated

    Tandem Diabetes Care, Inc.

    Revenue breakdown: Supplies And Other (52.5%), Pump (46.3%), Tandem Choice Program Recognized Deferred (1.1%).

    8-K
    Tandem Diabetes Care, Inc. furnished a press release as Exhibit 99.1 under Item 2.02 regarding results of operations and under Item 9.01. The filing discloses no specific financial metrics or details in the main body.

    $1.3B

    Market Cap

    $1.0B

    Revenue

    -$206M

    Net Income

    Employees2,650
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Supplies And Other52.5%($1.4B)
    Pump46.3%($1.3B)
    Tandem Choice Program Recognized Deferred1.1%($30M)

    Revenue by Geography

    US71.6%($1.9B)
    Non Us28.4%($768M)
    Activity

    What Changed Recently

    Material Agreement
    Feb 26, 2026

    Entry into a Material Agreement. Indenture and Notes On February 27, 2026, Tandem Diabetes Care, Inc. (the “Company”) completed its previously announced private

    Financial Results
    Feb 18, 2026

    and Exhibit 99.1 hereto is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    TNGXTango Therapeutics, Inc.$21.66+2.07%$2.5B-21.7
    KODKodiak Sciences Inc.$40.55-5.28%$2.1B-5.4
    NRIXNurix Therapeutics, Inc.$15.51+0.16%$1.3B-5.3
    SEPNSepterna, Inc.$25.20+3.43%$1.1B-21.5
    EYPTEyePoint Pharmaceuticals,...$13.41+3.00%$1.1B-4.6
    URGNUroGen Pharma Ltd.$18.84-0.53%$917M-5.5
    PHATPhathom Pharmaceuticals, ...$11.35+1.89%$894M-3.5
    FTREFortrea Holdings Inc.$9.46-0.58%$884M-0.9
    Analyst View
    Company Profile
    CIK0001438133
    ISINUS8753722037
    CUSIP875372203
    Phone858 366 6900
    Address11075 Roselle Street, San Diego, CA, 92121, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice